Who are Propofol, Lidocaine and fentanyl's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/propofol-lidocaine-and-fentanyl.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

Propofol, Lidocaine and fentanyl — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Propofol, Lidocaine and fentanyl (Propofol, Lidocaine and fentanyl) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Anesthetic combination (sedative-hypnotic, local anesthetic, opioid). Area: Anesthesiology / Sedation.

marketed Anesthetic combination (sedative-hypnotic, local anesthetic, opioid) GABA-A receptor (propofol), voltage-gated sodium channels (lidocaine), mu-opioid receptor (fentanyl) Anesthesiology / Sedation Small molecule Live · refreshed every 30 min

Target snapshot

Propofol, Lidocaine and fentanyl (Propofol, Lidocaine and fentanyl) — Kasr El Aini Hospital. This is a combination of three agents that work together: propofol (GABA agonist for sedation), lidocaine (local anesthetic blocking sodium channels), and fentanyl (opioid agonist for analgesia and sedation).

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Propofol, Lidocaine and fentanyl TARGET	Propofol, Lidocaine and fentanyl	Kasr El Aini Hospital	marketed	Anesthetic combination (sedative-hypnotic, local anesthetic, opioid)	GABA-A receptor (propofol), voltage-gated sodium channels (lidocaine), mu-opioid receptor (fentanyl)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Anesthetic combination (sedative-hypnotic, local anesthetic, opioid) class)

Kasr El Aini Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Propofol, Lidocaine and fentanyl — Competitive Intelligence Brief. https://druglandscape.com/ci/propofol-lidocaine-and-fentanyl. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab